← back to search

Dianxiong Zou

Texas A&M University · US
Area of research
Molecular Medicine · Nutrition and Dietetics
Research interest
Research interests include Medicine, Diabetes mellitus, Inflammation, Kidney, Internal medicine, and Transferrin receptor.
h-index
citations
49
works
3
NIH funding
primary concept
email

Recent publications

Nanocurcumin combined with insulin alleviates diabetic kidney disease through P38/P53 signaling axis
Journal of Controlled Release 2022cited by 29position: middledoi
Paclitaxel and Urolithin A Prevent Histamine-Induced Neurovascular Breakdown Alike, in an <i>Ex Vivo</i> Rat Eye Model
ACS Chemical Neuroscience 2022cited by 4position: middledoi
Nanoparticles that do not compete with endogenous ligands – Molecular characterization in vitro, acute safety in canine, and interspecies pharmacokinetics modeling to humans
Journal of Controlled Release 2021cited by 16position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

M. N. V. Ravi Kumar · University of Alabama at Birmingham3 papers (2021–2022)Raghu Ganugula · Texas A&M University3 papers (2021–2022)Meenakshi Arora · Texas A&M University2 papers (2021–2022)Erin M. Scott · Cornell University2 papers (2021–2022)Richard Friend · QIMR Berghofer Medical Research Institute1 papers (2022–2022)Rita Basu · University of Virginia1 papers (2022–2022)Nikhil K. Nuthalapati · Georgetown University1 papers (2022–2022)Dhaval K. Shah · New York University1 papers (2021–2021)Gladys Y.‐P. Ko · Texas A&M University1 papers (2022–2022)Stephen C. Pflugfelder · Baylor College of Medicine1 papers (2022–2022) · 1 papers (2021–2021)Srijayaprakash Uppada · University of Illinois Urbana-Champaign1 papers (2022–2022)David Sheikh‐Hamad · Michael E. DeBakey VA Medical Center1 papers (2022–2022) · 1 papers (2022–2022)